This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.
spk08: Greetings and welcome to the Maximus Fiscal 2020 Fourth Quarter and Year-End Conference Call. At this time, all participants are on a listen-only mode. A brief question and answer session will follow the formal presentation. If anyone should require operator assistance during the conference, please press star zero on your telephone keypad. As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Ms. Lisa Miles, Senior Vice President of Investor Relations for Maximus. Thank you, Ms. Miles. You may now begin.
spk00: Good morning, and thank you for joining us today. With me is Bruce Caswell, President and Chief Executive Officer, and Rigne Doe, Chief Financial Officer. I'd like to remind everyone that a number of statements being made today will be forward-looking in nature. Please remember that such statements are only predictions. Actual events and results may differ materially as a result of the risks we face, including those discussed in Item 1A of our Annual Report on Form 10-K. We encourage you to review the information contained in our earnings release today and our most recent forms 10Q and 10K filed with the SEC. The company does not assume any obligation to revise or update these forward-looking statements to reflect subsequent events or circumstances except as required by law. Today's presentation may contain non-GAAP financial information. Management uses this information in its internal analyses of results and believes this information may be informative to investors in gauging the quality of our financial performance, identifying trends in our results, and providing meaningful period-to-period comparisons. For a reconciliation of the non-GAAP measures presented in this document, please see the company's most recent quarterly earnings press release. And with that, I'll hand the call over to Rick.
spk03: Thanks, Lisa. impact on our operating results for fiscal year 2020. Bruce and I would like to thank all of our Maximus teams who, with incredible heart and dedication, worked tirelessly to keep us safe when we are required to work on site and transition staff to work remotely where possible. We adopted a hybrid operational model in March that enabled our teams to continue to operate essential programs in order to connect citizens to vital services in this pandemic-impacted world. As noted in our press release this morning, total company revenue for fiscal 2020 increased to $3.46 billion compared to $2.89 billion in the prior year. Approximately $330 million of the revenue increase was attributable to the Census Questionnaire Assistance Contract in support of the U.S. decennial census. The fiscal 2020 top line also benefited from new work in the US assisting with covert response efforts where we support governments with their public health responses in areas such as contact tracing disease investigation test results reporting coven information lines unemployment insurance claims processing and other coven related assistance. This work contributed to organic growth for fiscal 2020 of 15.7% or 4.6% excluding the census contract and was tempered by declines in our operations outside the US. While COVID related revenues increased as a result of the pandemic, our fiscal 2020 earnings declined. Our full year operating margin was 8.3% and diluted earnings per share were $3.39 for fiscal 2020. As we have explained previously, there are three primary areas of negative impact to fiscal 2020 earnings. One, we experienced reduced volumes on several large U.S. programs where both state and federal government clients instituted temporary program changes in response to COVID-19. This includes, but is not limited to, the halting of Medicaid redeterminations in our state-based business and a pause on the repayment of federal student loans in our U.S. federal services segment. There was a greater mix of cost plus revenue in fiscal 2020 driven by the census contract in the U.S. federal services segment And three, the outside the U.S. segment experienced a significant change in estimates for employment services work and a pause in face-to-face assessments. Our fiscal 2020 effective income tax rate was 25.3% compared to 24.2% in the prior year. The higher rate this year was attributable to normal course vesting of stock compensation, which had a reduced benefit tied to a lower share price. I will start my comments on segment results with the U.S. services segment previously named U.S. Health and Human Services. Revenue for the U.S. services segment in fiscal 2020 increased 13% to $1.33 billion compared to $1.18 billion last year. All growth was organic resulting from new contracts, including those to support COVID-19 response efforts and expansion of existing work. This allowed us to offset the temporary volume and revenue declines in certain core programs stemming from the pandemic. We estimate that the COVID response work contributed $129 million of revenue to the US services segment in fiscal 2020. As a reminder, the Families First Coronavirus Response Act provided states with a temporary increase in US federal matching funds for Medicaid if they meet certain requirements, which includes ensuring continuous care for Medicaid enrollees. This means Medicaid redeterminations have been halted so that individuals and families continue to have access to vital health care services during this global public health crisis. As a result, we experienced a significant revenue and profit headwind resulting from lower volumes on some of our largest Medicaid programs. Furthermore, state budgetary pressures have created the need to work closely with our clients to make adjustments to our scope of work to provide needed relief. As a result, the segment delivered an operating margin of 17.1% in fiscal 2020 compared to 18.8% for the prior year. Revenue for fiscal 2020 in the U.S. federal services segment increased to $1.63 billion compared to $1.11 billion in the prior year, driven most significantly by the $330 million increase of the census contract. Organic growth excluding the census contract was 8%. In fiscal 2020, the census contract delivered approximately $515 million of revenue, compared to $185 million in the prior year. The segment benefited from new contracts and new work related to COVID response efforts. We estimate that our COVID response work contributed approximately $71 million of revenue to the U.S. Federal Services segment in fiscal 2020, which excludes the increases to the census contract tied to the pandemic-related extended response period. On the bottom line, The segment delivered an 8.1% operating margin for fiscal 2020, reflecting multiple sources of downward pressure, including a greater mix of cost plus revenue in fiscal 2020 related to the census contract and the contact center operations contract, which is also known as 1-800-Medicare. Both contracts carry lower margins due to their cost plus nature. Reductions in volumes, revenue, and profit from performance-based contracts were a result of the pandemic. For example, there is a pause on student loan repayments impacting our Department of Education contract. And as I discussed last quarter, we continue to see much lower workers' compensation claims compared to pre-COVID levels. Investment in business development and marketing is ongoing as we further expand into the U.S. federal market. As you are probably aware, there is a lag from the time of investment until we begin to get traction. This lag has increased due to the pandemic. However, we made progress in expanding our scope in certain agencies, like the IRS, where we support the agency in responding to general inquiries regarding the CARES Act and the payments under the Economic Impact Plan. This is the first time the IRS has used a public sector partner for citizen engagement at this scale. Fiscal 2020 revenue for the outside the U.S. segment was $498.9 million compared to $599.1 million in the prior year. The segment experienced the most pronounced impact from the pandemic and finished the year in a lost position. our employment services businesses realized a significant decline in the number of employment opportunities available to those individuals looking for work, which caused us to take a write-down to unbilled receivables of $24 million in the second quarter. Since then, operating performance for this segment has improved each quarter, and the operating loss was less than $1 million in the fourth quarter of fiscal 2020. In addition, approximately one-third of this segment's revenue is tied to our health assessment advisory services contract in the United Kingdom, where face-to-face assessments were suspended in March. As a result, the program is operating at reduced levels of activity. While the segment continued to operate at reduced activity levels across both our major programs and our emerging market territories, in the second half of fiscal 2020, we currently expect an improved outlook in fiscal 2021. Based on what we know today, we are forecasting that the segment will deliver top-line growth in fiscal 2021 of approximately $175 million over the prior year. This is predominantly driven by rising unemployment and forecasted volume increases in our employment services contracts that support individuals into long-term sustained employment. We are already starting to experience increased volumes in markets that are beginning to emerge from the pandemic, such as Australia. The segment is also expected to benefit from new work wins that will generate revenue and profit in fiscal 2021. On the bottom line, we expect the segment to remain in a lost position in the first half of fiscal 2021 with a return to profitability in the second half of the year. Lastly, it is important to note that our outlook may continue to be impacted by the pandemic, but Maximus remains exceptionally poised to help governments navigate significant challenges as the world emerges from the global pandemic. Let me turn to cash flow items and the balance sheet. For fiscal 2020, cash flow from operations was $244.6 million, and free cash flow was $203.9 million. Cash from operations was negatively impacted in the year due to the additional investment in working capital required by increases in revenue and the timing of collections. DSO was 77 days at September 30, 2020, compared to 72 days for the same date last year, which accounts for $50 million of the increase in our accounts receivable. There was also an increased level of investment in working capital for increased receivables resulting from the higher revenues we had in the fourth quarter this year, $924 million, compared to the fourth quarter last year, $755 million. Assuming 72 days DSO, that increase in revenue caused an increase in receivables of $130 million. We studied the historical relationship of our free cash flow and net income And being a high-cash conversion business, these two metrics are closely correlated looking back to fiscal 2014 on a cumulative basis. We expect lower revenues in the fourth quarter of fiscal 2021 compared to fiscal 2020 and accordingly expect free cash flow to be higher than net income in fiscal 2021. We finished fiscal 2020 with $71.7 million of cash and cash equivalents. During the quarter ended September 30, 2020, we paid down all of our draws on our corporate credit facility. Let me touch on capital allocation. We continue to manage the business conservatively. Liquidity is not a concern, and while we generally operate under an essential service provider designation, we are keenly aware of budget pressures impacting our customers. We previously indicated that any large-scale M&A was paused while tuck-in transactions would continue. Given our current financial standing, proof of our ability to successfully operate in the pandemic, and strong debt markets, we restarted our M&A activities as new prospects come to market. We do not anticipate a disruption to our future quarterly cash dividends. Share purchases will continue to be made opportunistically. We believe it is critical to make ongoing investments in our business, particularly in our people, processes, and technology to enable uninterrupted delivery to our clients while maintaining our competitive edge. In closing, we are establishing guidance for fiscal 2021. Revenue is projected to be between $3.2 billion and $3.4 billion, and diluted earnings per share is projected to be between $3.45 and $3.70. This is a wider range than prior years due to the significant uncertainties we face in predicting the amount and duration of the COVID response work and the disruption to core programs across all of our segments. As a reminder, the census contract is in the wind down phase. We expect approximately $460 million less revenue from this contract in fiscal 2021 compared to fiscal 2020. Proforma revenue in fiscal 2020, adjusting for the change in the census contract, is approximately $3 billion. Against the midpoint of fiscal 2021 guidance, which is $3.3 billion, this implies organic growth of approximately 10%, excluding the census contract. This anticipated growth is driven by two main factors. Significant top-line growth from operations outside the U.S., where, as I noted earlier, we expect revenue increases of approximately $175 million, primarily due to forecasted volume increases on our employment services contracts and new work coming online, and forecasted resumption of activities and volumes of core program work within our U.S. services segment. Looking forward into fiscal 2021, it is difficult to predict when the COVID response work will end and when our core programs may return to previous profitability levels and whether these two will coincide. Our profit performance for fiscal 2021 is expected to lag revenue performance for all three segments, which reflects the pandemic-related challenges, such as lower volumes in many large U.S.-based programs, For example, Medicaid eligibility redeterminations were suspended to ensure people continue to have insurance, which is the main driver behind the reduced volumes. However, the modest increases we have experienced in some Medicaid enrollments has not been sufficient to offset the impact from halting Medicaid redeterminations. All of our Medicaid contracts have different terms which result in varying revenue impacts as a result of these dynamics. Fiscal 2021 cash from operations is projected to be between $340 and $390 million, and free cash flow is expected to be between $300 and $350 million. Our effective income tax rate is expected to be between 25.75% and 26.5%. Weighted average shares in the fourth quarter of fiscal 2020 were $62.3 million. Absent share purchases, we would expect the weighted average shares in fiscal 2021 to be between 62.1 and 62.2 million. We expect the U.S. services segment operating margin to be in the 16.5 to 17.5 percent range. We expect the U.S. federal services segment operating margin to be in the 6 to 7 percent range. The outside the U.S. segment is expected to have positive operating income, but this segment continues to be more severely impacted by the pandemic than the two U.S. segments. And, accordingly, operating margins in the low single digits for the full fiscal year is a reasonable expectation. As I noted earlier, we expect the outside the U.S. segment profit to be slightly negative in the first half of the year, with improvement occurring in the back half of fiscal 2021. Predicting the quarterly profile is challenging. Much of our COVID response work is scheduled to conclude after our first quarter ending December 31, 2020. Based on our current assumptions, this means that the second quarter of fiscal 2021 is likely to experience a significant drop in revenue and earnings. While it is possible that some of this work will be extended, this is not guaranteed. It is also difficult to predict when the public health emergency declaration will cease, when the U.S. federal government will permit states to execute redeterminations, and when other core programs will return to previous levels. We hope that these remarks provide you with insight into our fiscal 2021 based on what we know today. And with that, I will turn the call over to Bruce.
spk06: Thank you, Rick, and good morning, everyone. The U.S. 2020 general election is top of mind for us all, so I want to start there. While some uncertainty remains, such as with the Georgia Senate runoffs in January, we're in a good position to address our perspectives on the Biden-Harris administration and congressional results, as well as some anticipated implications for Maximus. As some expected, the projected blue wave did not materialize, creating a likely indicator of a more moderate approach by Congress and the new administration for at least the next two years. Generally speaking, therefore, there are headwinds and tailwinds as Democrats have tended to design and promote more generous social welfare and public health programs, while Republicans tend to focus on program integrity as it relates to access, coverage, and eligibility criteria. As we've seen through our own history serving government, both parties see value in public-private program delivery models, often for different reasons. A good example of this developed during the pandemic. when the volume of unemployment claims quickly overwhelmed traditional state resources. 37 states have turned to contractors for unemployment insurance application processing assistance under the authority of the CARES Act, with 21 under Democratic governors and 16 Republicans. We've been fortunate during this period to secure unemployment insurance work with 17 states, both Democrat and Republican. As you know, our nation continues to face a variety of challenges, including a global pandemic and subsequent high levels of unemployment, impacting specific sectors of our economy and straining social welfare and health safety net programs. Both Congress and President-elect Biden will need to address these challenges and do so in the context of record deficit spending. For decades, Maximus has been a partner to government as it navigates the impacts of economic shocks and uncertainty that simultaneously drive greater reliance on program benefits while challenging budgets, particularly at the state level. As Rick described, our role as a partner to many state Medicaid programs is to ensure policies are quickly and effectively implemented to enable ongoing access to health benefits for vulnerable populations. In other cases, like our student loan programs and unemployment insurance, Our role is to help reduce fear and bring hope to many in difficult financial circumstances. Our view is that the near-term headwinds of lower volumes in some programs are far outweighed by the long-term tailwinds of being a decades-long partner to government, entrusted with the administration of some of the most critical social welfare programs in our nation. So while some of our core programs may be a long way from resuming previous operational levels due to the sheer uncertainty of the times, We're managing our costs prudently, investing in new capabilities, and we'll be ready as the next equilibrium emerges. Turning to current events, as most of you know, the Supreme Court last week heard arguments in California v. Texas, which challenges the Affordable Care Act's constitutionality by focusing on the individual mandate. We cannot know for certain when the court will issue a decision or what their decision may be. However, recent press coverage has pointed to the court signaling its intent to keep the Affordable Care Act in place. With healthcare policy being a top priority and a major platform initiative for President-elect Biden, we anticipate actions to address certain aspects of the ACA through a number of levers, from executive orders to agency regulations to potential congressional action. These actions will focus on giving Americans more choice, reducing healthcare costs, and making the healthcare system easier to navigate. And when it comes to understanding the intersection between customers and public health insurance programs, Maximus is uniquely positioned. For years, we've supported the federal government and states with the implementation and ongoing operation of the ACA and subsequent modifications. Our demonstrated success in supporting state and federal exchange marketplaces under the ACA will enable us to assist the new administration in their efforts to improve access to benefits and streamline the citizen experience. The Biden administration is already taking steps to prepare their transition team. As a result, we don't expect the same level of slowdown in federal procurement as we saw with the 2016 transition. In summary, the long-term demand for our services remains strong as federal and state agencies turn to companies like Maximus to deliver outcomes that matter for their citizens. Amidst the U.S. election period, the COVID-19 global pandemic continues. I'm proud to share that we have hired thousands of new employees in fiscal 2020, despite the pandemic. In a small but meaningful way, we are proud to have created new opportunities for many in the face of historic levels of unemployment. Many of these positions operate under a work from home model or offer temporary work from home capability throughout the pandemic. As you may recall, many of our operations were deemed essential by our government clients. And while we strive to move as many employees to a work from home model as possible, Not all government programs allowed for this, particularly those with strict requirements related to the handling of personally identifiable information, or PII. At peak, we successfully transitioned 63% of our U.S. workforce to work from home, with 32% in an office setting and the remainder on leave. Outside of the U.S., 76% of our employees shifted to a work-from-home model at peak. This prompted us to conduct an employee survey of our U.S. employees regarding our COVID-19 response and safeguarding measures. Of note, 80% of respondents believe Maximus is protecting their physical health and safety, and 80% also believe Maximus has taken necessary steps to provide appropriate income protections. This employee feedback will continue to guide our COVID-19 Action Committee and ongoing strategy as we face rising levels of the pandemic again. Most importantly, we have a sharp focus on managing and executing the business during this global health crisis, while protecting our employees remains paramount we aim to meet our contractual obligations achieve our profitability objectives generate strong cash flow and continue to drive organic growth. During this period we've capitalized on several new opportunities. In support of our strategic expansion into clinical BPO services delivered at scale, we formed Maximus Public Health, or MPH, to provide meaningful support to governments as they respond to COVID-19 and other public health threats. The team comprises public health clinicians, researchers, epidemiologists, biostatisticians, and geospatial analysts. MPH is collaborating with academic partners, conducting research and expanding partnerships with public health agencies, healthcare providers, data analytics platforms, and industry partners to serve as a resource to government in developing and executing their public health strategies. This collaboration focuses on preparedness and effective response to current and future healthcare crises. Initially, MPH is supporting efforts to contain the spread of COVID-19 and toward the purchasing, distribution, citizen engagement, and administration of vaccines. As we've grown, our array of services has become more robust. As a result, we've renamed our U.S. Health and Human Services segment to the U.S. Services segment. This better represents the breadth of offerings provided by the segment for our government clients. Our digital transformation and early technology investments enabled us to successfully pivot in the face of the pandemic and effectively serve those most reliant on the public programs we operate. Earlier in our digital transformation journey, I shared the success as we disrupted traditional models and developed the tools to meet citizens where they are through mobile applications, robust portals, and omnichannel communications that seamlessly integrate chat and text messaging with conventional voice channels. Internally, we've applied robotic process automation, or RPA, at scale, and last week our bots processed their two millionth transaction. We continue to see strong potential in RPA to contribute further to operational efficiencies. With these accomplishments as our foundation and our customers coming to expect digital capabilities tightly integrated with our BPO solutions, now is the time for us to move to our next phase. We will continue maturing our digital delivery capabilities and driving further automation into routine citizen transactions. while taking the next steps to build on the potential that our movement to the cloud has created in areas like natural language processing, AI, and cognitive computing. Our COVID-19 digital response is an early indicator of those efforts, and I will share more as we continue along this trajectory. I'm pleased that we successfully cemented our place on the U.S. Department of Education's Office of Federal Student Aid, or FSA, Next Generation Processing and Servicing Environment, known as the Next Gen Contract Vehicle. As a reminder, Maximus currently provides customer service to more than 7.5 million students as part of the Debt Management and Collections System, or DMCS, project at FSA. The NextGen contract vehicle will allow us to bid on task orders that will ultimately provide resources to support all student interactions with FSA. For example, this would include task orders tied to allocated volumes of the loan portfolio that will be converted to the new servicing model under NextGen. As FSA transitions to the NextGen strategy, Maximus will continue to provide ongoing support and delivery for the FSA DMCS. This work is core to our offerings and illustrates our growth strategy to further expand in U.S. federal government agencies. Outside of the U.S., Maximus has secured an industry-leading position on the new U.K. government commercial agreement for the provision of employment and health-related services. or CARES framework, winning a place in all six areas on which we bid. The framework will be used by the UK government for contracting national employment support programs. This framework is expected to be the default vehicle for the Department for Work and Pensions, or DWP, national employment-focused program contracts. Maximus is already working with the government commissioners in the UK to utilize our expertise to address labor market challenges caused by COVID-19. For example, over recent months, Maximus has worked with the DWP to expand our employment-focused programs, launching new initiatives in Wales and London. We believe our existing delivery, along with our record of performance and strong partnerships, puts us in a sound position when procurement for future contracts begins shortly. The UK is no exception, and as Rick noted, we are seeing a substantial rise in demand for employment support programs across all of our markets as governments struggle with rising unemployment. These trends point to a significant increase in revenue outside the U.S., where Maximus already has a large portfolio of employment services contracts. We have a long and successful track record of achieving employment outcomes and supporting people back into sustainable work during economic downturns. These programs will be essential as governments aim to get their economies back on track as we emerge from this global pandemic. Moving on to new awards and pipeline as of September 30th. For the fourth quarter of fiscal 2020, signed awards were $2.670 billion of total contract value at September 30th. Further, at September 30th, there were another $744 million worth of contracts that had been awarded but not yet signed. Let's turn our attention to our pipeline of addressable sales opportunities. Our total contract value pipeline at September 30th was $33.0 billion, compared to $28.9 billion reported in the third quarter of fiscal 2020. Of our total pipeline of sales opportunities, 69.3% represents new work. I want to reiterate the difficulty in predicting the impact the global health pandemic, the uncertainty around the Senate majority, and the new U.S. administration transition may have on our pipeline, timing of new work, and return to previous operational levels. However, we've fared well through the pandemic, and we've worked through presidential transitions with success in the past. Our earned reputation as a trusted partner offers continued opportunities to assist governments through these extraordinary times. In fiscal 2020, we demonstrated our ability to respond to the changing needs of our clients by capitalizing on strategic and timely IT investments, using our digital capabilities and leveraging our experienced teams to quickly ramp up a qualified workforce. Our long history of success working with our government clients positioned us to effectively respond to the extraordinary needs of citizens in the wake of the pandemic. We're cautiously optimistic that fiscal 2021 will be a year of progressive stability across the business, strong execution, and strong cash flow. While the global pandemic continues to impact many of our core programs, they will ultimately return to previous levels in the future. It really is not a question of if, but rather a question of when. Before closing, I'd like to reinforce comments I've previously made regarding our commitment to diversity, equity, and inclusion, or DE&I. We recently hired our senior director of DE&I, who will focus solely on furthering our strategy and implementation across the business. This includes extensive listening sessions with employees and engaging them in the process of defining future programs and initiatives. These initiatives will strengthen not only our company, but speak further of our commitment to the communities we serve. While I'm pleased with the progress we're making, I'm reminded that there is more work ahead. In the U.S. alone in fiscal 2020, we've successfully employed more than 2,100 persons with disabilities, and more than 71% of our total U.S. hires are female. We continue to refine our focus on recruiting people of color and military veterans at all levels of the organization to better reflect the populations we serve. I spoke recently with our newly hired manager of veterans outreach, who is herself a veteran and Paralympian, and share her optimism at the progress we've made and the further potential we have to create opportunities for those who have served so honorably. And lastly, for our Maximus colleagues who have been impacted by COVID-19, we remain steadfast in our commitment to provide assistance where we can for you and your loved ones. And with that, we'll open the line for Q&A. Operator?
spk08: Thank you. Ladies and gentlemen, we will now be conducting the question and answer session. If you would like to ask a question, please press star 1 on your telephone keypad. A confirmation tone will indicate that your line is in the question queue. You may press star 2 if you would like to remove your question from the queue. We ask that you limit your follow-up questions to 1 so that others may have an opportunity to ask questions. You may re-enter the queue by pressing star 1 again. For participants using speaker equipment, it may be necessary to pick up your handset before pressing the star keys. Our first question today is coming from Charlie Strasser of CJS Securities. Please go ahead.
spk02: Hi, good morning. Rick, maybe you can explain a little bit more on your margin assumptions for next year, specifically in the OUS. Are you kind of expecting to see a kind of typical ramp of, you know, upfront expenses to support, you know, higher expected caseloads there?
spk03: A good question, Charlie. A significant portion of next year's growth, as you note, in the OUS segment is driven by contracts that are currently signed and in the Maximus contract portfolio. This includes a lot of new programs such as our job entry targeted support program we call JETS in the UK, an employment program that's targeting recently unemployed people due to the pandemic. Participants participate in The program provides tailored, flexible support to get participants back to work, including specialist advice on resumes and interview coaching. Yes, we're beginning to see the rise in caseloads in markets as certain economies emerge from the pandemic. That includes Australia. Yes, you're right. Q1 and Q2 are going to be impacted by headcount growth as we prepare for those increased volumes. Q2 would also be impacted by seasonality. It's normally a slower period for employment services contracts. And as you know, pending change orders can always be a factor with respect to timing. Remember, we had a write-down in the second quarter this year of $24 million as a result of the pandemic and the impact of the pandemic on our employment services future outcomes. That is obviously not expected to be forecasted to repeat.
spk02: I hope that answers your question. That's great. Thank you. And just my follow-up is probably for Bruce. Maybe you can give us a little bit more of your thoughts about the incoming administration and some of the longer-term opportunities that you might see from the Biden administration. Thank you.
spk07: Sure, Charlie. Again, as you well know, we get this question a lot, which is what might this administration mean? It's complicated, so we always start by reiterating what we've said for some time, which is that Democratic administrations tend to spend more and outsource less, and Republican administrations, it's generally been the opposite. But with that, with the global pandemic as a backdrop, we believe strongly that social welfare programs and, of course, public health programs are likely to see a meaningful increase in funding under a Biden administration. We also know that access to affordable health care is a top priority of the Biden administration. And the president-elect has certainly advocated to build upon the Affordable Care Act, and we'd expect him to do that through a number of means. That could be executive orders and regulatory means. Of course, the outcome of the special Senate election in Georgia is an overarching consideration here because more broader measures that might be required congressional action obviously would hinge on that outcome. But the underlying premise is to provide greater coverage for Americans. Some of the things that the President-elect has spoken about include increasing access to individuals to a public option. What does that mean? One thing is potentially to expand the age of eligibility for Medicare, making Medicare an option for individuals that are 60 to 65. Other factors that you might see implemented would include eliminating the income cap for tax credit eligibility under the Affordable Care Act, which is now capped at 400% of its federal poverty level. As a reminder, 400% of its federal poverty level is about $100,000 per family of four. In addition to that, the President-elect talked about increasing access to a public option for individuals in the 14 states that don't presently have access to Medicaid through Medicaid expansion. And that's about 4.9 million individuals that gain access to that one. So the next question is, what role for Maximus? My view is that the President-elect really had a front-row seat in the implementation of the Affordable Care Act. And he's a very experienced government executive. He's bringing together a team of career government officials that have a lot of experience in prior administrations. And I think they likely will take a very pragmatic view of the complexity of implementing significant programs and enhancing programs like the Current Affordable Care Act, creating a public option. So private sector partners like Maximus, I believe, will continue to be a key component of supporting the efficient delivery of high-quality and essential government programs like this. And then finally, as I mentioned in my prepared remarks, I talked a little bit about Max's public health. We expect there to be continued extraordinary investments in public health, as we've seen over the past six months, now turning to the distribution, administration, and access for consumers to vaccines in light of some of the shortcomings that we've seen in our public health system during the pandemic. So I take all those factors together and add them all up. I'd say that we're cautiously optimistic regarding the next four years under a Biden-Harris administration.
spk08: Thanks, Bruce. Thanks, Charlie. Next question, please. Thank you. Our next question is coming from Donald Hooker of KeyBank Capital Markets. Please go ahead.
spk05: Great. Good morning. Thank you for the questions. So I wanted to dive into sort of the Medicaid challenges that you're facing and try to understand the dynamics here. I understand the redeterminations here. Does this sort of, is this going to snap back perhaps next year? How does this work? Is this all linked to the public health emergency? So at some point that's lifted and then you guys see sort of a snap back and work, maybe even catch up work relating to the sort of Medicaid redeterminations that had been suspended. Can you walk me through that?
spk07: Sure. I will give you a quick answer to the end part of your question. Yes, we believe that the redeterminations that are building up now in BAPLOG will have to be addressed at some point in the future. So like we said during my prepared remarks, it's really not a question of when as it relates to that. Now, a few things quickly on the redeterminations. Another word for this is kind of maintenance of effort. States have to maintain their level of effort on Medicaid, and that's providing access to individuals for health benefits emergency. An interesting kind of nuance is that the enhanced federal matching money, the 6.2% that states are getting during this public health emergency, extends through the end of the order in which the public health emergency ends. So presently, Secretary Azar announced a 90-day renewal of the declaration that takes the public health emergency through the end of January, actually through January 20th of 2021. The funding, therefore, would be available to states through the end of March. The maintenance of effort requirement, however, ends in the month in which the public health emergency ends. So it would end in January of 2021. So they get some additional funding, but they could resume redeterminations in that quarter. Then the question is, what's happening with Medicaid enrollment? I think it's, you know, and we've talked about this before, Don. We've, you know, been studying very closely the relationship between unemployment and Medicaid enrollments, and a couple interesting facts. One is that Medicaid enrollment has increased between August of 2019 and July of 2020, which is the period for which most recent data is available, by about 4.2 million individuals, or 6.6%. Interestingly, for adults, it's increased 8.4%. So we have already seen some enrollment increases in our state Medicaid contracts, but as we indicated during our prepared remarks, the tailwind of these increased enrollments, which nationally has been about 1.6 to 1.2% per month, has not yet been sufficient to overcome the headwinds from the reduction, or I would rather call it the temporary suspension of redeterminations. But there will come a point, right, where that flips and redetermination backlogs are there that then need to be worked. Hope that helps.
spk05: Yeah, I guess maybe for just, can you give us a sense as to maybe roughly quantify that? Is there going to be sort of a step up that occurs? I mean, who knows when the public health emergency ends, but is there What was the headwind from that pause in redeterminations?
spk07: Yeah, well, I would point you just back to the guidance that we just provided. We have baked that into our view for FY21 based on the current, you know, end date for telehealth emergency that I mentioned. And so if there's going to be an increase in the work related to redeterminations and further eligibility and enrollment work, that would be incorporated obviously in the second half of the year in our guidance.
spk05: Okay. Thank you so much. Thank you, John.
spk08: Next question. Next question, please. Thank you. Our next question is coming from Richard Close of Canaccord Genuity. Please go ahead.
spk04: Great. Thanks. Congratulations on the year given everything that's been going on. first question may be to dive in a little bit deeper on the outside the US Rick appreciate your comments on the profitability there but you know as we think about employment services whether it's the UK or Australia it has been challenging you know maybe over the last five years or so With that, programs changing and whatnot, can you just talk a little bit about your confidence with respect to the new contracts that you're seeing and then the opportunity on the employment services? You mentioned Australia improving some. Just trying to gauge what your confidence level is with respect to that business.
spk03: Sure, Richard, and all good questions. And yes, you're right. We have struggled with the high employment rates and the low unemployment rates historically. 50% of our work outside the U.S. is in that employment services area. And as you know, they're volume-based contracts where we get paid for outcomes. When you have low unemployment rates, you're going to be struggling with the level of activity and volumes. And so that has been our historical issue. You know, unemployment rates are rising now, but that's as a result of the pandemic. And we've had climate change. see the volumes appear, and we are beginning to do our hiring in advance of those unemployment volumes. So yes, I mean, these are contracts that are in the portfolio and signed today, and we're beginning to see the signs of the volumes appearing, and we are starting to do the hiring that we're going to need to service those volumes. Does that answer your question?
spk04: Yeah, I guess. Moving on. Give me a follow-up then. Well, I mean, I can get with you. You know, I mean, the contracts, the programs, I should say, have changed over the years. And, you know, maybe especially in the UK. And I'm Just trying to gauge, are we going to start this program, and then after a year or so, they're going to say we're moving on to something different. There's just been a lot of changes, and it seems like it's created a lot of noise over the last four or five years.
spk03: Yeah. Okay. Well, two points. One, by the way, in the United Kingdom, we are on cost reimbursement at this particular point, which was good for us. We typically prefer pay for results, but obviously in the pandemic world, that was helpful to us. And they did change the payment structure in Australia to help us so there was a little less payment results oriented. So as we go forward, I mean, I think You know, if we continue with reasonably high unemployment rates, then the programs that we have are going to be required. And I think that we're going to be called upon to service those. If we get back into low unemployment rates in, you know, 2023, 2024, you know, you've seen history. History told the, you know, had the governments tell us to begin to work on other types of things and harder to serve populations. And so it'll be more challenging for us.
spk04: Okay, that's helpful. Do I get to ask a follow-up, or did I use that? Sure.
spk00: Absolutely, Richard. Okay.
spk04: So maybe not to be negative, but on Maximus Public Health, obviously that's a great opportunity for you, I think, given everything that's going on and vaccines and whatnot. But, you know, if I look at the census, obviously there was some investor interest in the drop off of the census once that program comes to an end. So as I think about Maximus Public Health, you know, at some point, hopefully this COVID situation comes to an end. Bruce, I'm curious your thoughts in terms of investing in the buildup of MPH and the opportunities that exist there, and then thoughts of what happens after you know, the waters under the bridge or over the bridge, whatnot, with respect to the need for the Maximus public health business.
spk07: Absolutely, Richard. And I'd say you're characterizing it correctly. The water right now is over the bridge and hopefully it'll come back down. Our intent in making this investment is that it is actually a component of our long-term strategy to become more clinical as a company. And so I'm glad you asked the question because it's not a knee-jerk reaction to a one-time crisis, but rather an investment that gives us a team of folks with an incredibly diverse set of skills and backgrounds that can help our customers as they not only attack the current global pandemic, but one of the big lessons learned from this pandemic was that a lot of people just weren't ready. And so we do need to be mindful of the fact that there could be further pandemic situations, hopefully not of the size that we're seeing presently, but over the course of the next several decades. Number two, this is a team that has tremendous experience and background in a lot of areas of public health, and public health crises are significant around the world. In particular, the percentage of populations with non-communicable disease states and chronic conditions and comorbidities. And so we've actually, we're having this public health team be resident within our federal organization, but it's really an asset to the entire company. And as I've spent the last few days on our business development calls going around the world, we've had representatives from the public health team on the phone talking with folks in our Asia Pacific region and our Gulf region and so forth about the public health crises that a lot of those governments are facing. Candidly, during the COVID period, access to appropriate mental health services for large populations is becoming more and more important. But then there are also countries that have significant public health issues as it relates to diabetes and obesity and other chronic conditions. So this is an organization that is incredibly well-equipped in the near term because, for example, its leader, Dr. Andrew Somers, previously worked in the Office of Health Policy for the Assistant Secretary of Planning and Evaluation at HHS and worked on things like Zika and Ebola prior to pandemics. But the team is broad enough and their experience is deep enough that they can certainly help us on the broader public health mission that we're executing on, which is part of our clinical evolution strategic thrust as a company.
spk04: That's a great answer. Thank you very much for allowing me to ask that question. Congratulations.
spk00: Thanks. Thanks, Richard.
spk08: Next question, please. Thank you. Once again, ladies and gentlemen, if you would like to ask a question, you may do so by pressing star 1 on your telephone keypad. Our next question is coming from Dave Stieblo of Jefferies. Please go ahead.
spk01: Hi there. Good morning. Glad to see Richard got a mulligan in. That's fair. First question I had, and I missed the first 40 minutes, so I apologize if you've covered this already, but to circle back to the guidance, the revenue outlook, $3.3 billion at the midpoint seems quite a bit higher than what you were signaling during the last call. although the EPS seems pretty consistent, and you were trying to talk that down from where consensus was, and consensus listened to some extent. So I'm curious, why aren't we seeing the same EPS flow through as we are on revenue being higher than what we were thinking it should be? It sounds like maybe there was some investments. Is that sort of the overhang right now, or are there other explanations for that?
spk03: Dave, Rick, how you doing? Yeah, it's a good question. And we are looking at, and obviously the answer is many different factors. We are seeing some revenue reductions on performance-based contracts resulting from the COVID pandemic. As I indicated in my prepared remarks earlier, We have seen some pause in student loan repayments which have impacted our debt management contract. Last quarter I provided the example of the impact of workers' compensation claims in California on our independent medical records review on workers' compensation claims. We did talk about the suspension of redeterminations in the United States on the Medicaid. You know, when we do, we are filling in a lot of things with the COVID response work. That is a creative work, but it's coming in at margins that are less than our average. And it puts some downward pressure on us there. marketing, particularly in our U.S. federal segment, which we, I believe, can be a growth area for us. And we also previously talked about, you know, developing technical capabilities that are tied to those growth initiatives. So I think what you're seeing is, yes, lower margins with better revenue. And I really blame it on the pressure on some of our core work to And then us filling in the top line with that COVID response work, which really doesn't have as good a margin, but is accretive, as those core programs.
spk01: Got it. Okay. And then my one follow-up would be on the new work in the pipeline. It looks like to me, using some back-of-the-envelope math there, that it's up about 17% sequentially from the fiscal third quarter. Looks like most of that is in RFPs that haven't dropped yet, but I'm curious just to, one, confirm that, and two, understand if you can provide any color if that's related to maybe just a couple of contracts that have larger dollar revenue opportunities or if there was just a series of contracts that are now coming to market in the RFPs.
spk07: Why don't I start and then ask Rick to add some color commentary as well. So we provide a little bit of color on the pipeline and new work in our presentation, obviously, and the press release as well. And I would say that if I look at kind of the composition of the pipeline, it's interesting. you know, about three, four months ago, I would have told you that the federal government pipeline was largely kind of unchanged. Deals were flowing through. Most of the disruptions of any were at the state level because states were shifting so hard to do kind of emergency pandemic-related procurements. And in addition to that, outside the U.S., we saw some slowdowns in some particular areas, but otherwise, you know, kind of moving ahead. The answer now is that the federal government still in a few agencies, has had to prioritize the pandemic themselves. And so if I look at CMS, some of the deals that we would have seen in the pipeline this year are being pushed out at least a year. Now, that's good if you're the incumbent. You're just getting contract extensions. But if you're hoping to go after it, it's not. Other agencies, it's a little bit more mixed. Like at the IRS, on the one hand, we've benefited from the procurement in the customer contact center environment, which is the first kind of first of a kind at the IRS in a federal government agency that we've been hoping to serve for years and are proud to serve now. But there were other procurements that were delayed as well. So at the federal level, it's, I guess, Final point I'd make would be it's been good to see that some of the transformational procurements that are the larger, kind of longer-term ones have continued apace, and the FSA next-gen one being probably the best example that we've recently, you know, won a seat on. So with that as a bit of the backdrop, the composition of the pipeline still remains strong. We've seen, I would say, additional RFP opportunities still coming out as it relates to contact tracing work. As the second wave has hit, at the U.S. services level, it seems like there have been some RFPs that were developed and kind of waiting to be launched that are now coming out that have the potential to extend the contact tracing work further into the year than we might have anticipated. And then from an outside the U.S. perspective, I guess the key point I'd make there is that a number of geographies like the Gulf region and Australia are in a much better condition compared to obviously the U.K. or the United States as it relates to COVID. And so, procurements have actually moved ahead nicely and the pipeline is interestingly quite robust. I will also say Finally, on the outside of the U.S., there are customers that have seen the pandemic as an opportunity to rethink and reshape their programs. And they've thought in a very transformational way about it and said, you know, we're going to move to more digital solutions. We're going to change the way we deliver our programs. And we even have examples where our fees have been accelerated because they want to capitalize on the moment.
spk03: So I hope that provides a bit more color. And Rick, is there anything further you'd ask? No, sure. I just want to just make sure that, you know, we say again, I mean, all of this has been built into our guidance. You know, the amount of uncertainty that we face at this particular time, you know, is unprecedented in our recent history. And, you know, that's both upside and downside. So, you know, we've done the best we can to, you know, put all of that in our guidance.
spk01: That's good. Thanks. I'll let others go.
spk08: Operator, next question please. Thank you. Our next question is coming from Richard Close of Canaccord Genuity. Please go ahead.
spk04: Yeah, thanks. I'll keep it quick here. With respect to the employees, I think it's slide 12, 80% survey. on your employees. Can you talk a little bit about, you know, who's required to be in the office? And maybe just, you know, give us a little bit of an update with respect to that and the 80%. Do you do these surveys on a regular basis? And any thoughts in and around those metrics?
spk07: As I mentioned during my prepared remarks, at our peak, we were able to transition 63% of our U.S. workforce to work from home. And outside the U.S., it's actually 76%. Not all customers are able to have us work in a model with everybody working from home. So in some instances, for example, supervisors need to be in the office. to remotely monitor and manage the employees that are working from home. Another factor is training. We found that over time, in a number of our programs, training is best delivered initially in an on-site manner, and that gives individuals an opportunity to not just learn the material, but ask questions and then go through what we call a nesting process, where they're taking their initial calls in a very closely monitored environment, and then they can develop to the point where they may be able to then go and work from home. So in every instance, we've obviously been super careful to maintain appropriate protocols in all the facilities so that we're staffing at appropriate levels given local conditions and rules because often local governments might limit the kind of percentage occupancy in facilities and so forth and ensure that we're keeping our employees safe. You'd asked about how frequently we survey our employees. We've surveyed them more frequently during COVID than maybe historically, because we really want to get a sense of how we're doing by them. We want to make sure that they feel that they're being protected in the workspace and that their income is being protected appropriately as well, and hence the statistics that we offer during the call. We're moving as a company toward an annual employee survey where we'll look at effectively kind of a net promoter score number that will give us an indication of employee satisfaction with what we're doing. And we began this actually shortly after my becoming CEO, and we really work hard to address factors that are so critical to our employees, like the feeling of whether they're supported by their supervisor, whether they're getting adequate opportunities for career development, and so forth. So, employee engagement is a very important factor, and a close cousin to that, of course, is in the area of diversity, equity, and inclusion that I mentioned during my remarks. Okay, thank you. Yep.
spk00: Richard, operator, do we have any further questions?
spk08: We do not have questions at this time. Ladies and gentlemen, we have reached the end of the question and answer session and are out of time for today's call. Maximus thanks you for your time and participation, and you may disconnect your lines at this time.
Disclaimer